Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer (Q57975577)

Catherine S.M. Diefenbach

1

0 references

Jason Konner

Jason Konner

9

0 references

Richard R Barakat

4

Richard R. Barakat

0 references

Alexia Iasonos

3

Alexia Iasonos

0 references

Howard T Thaler

13

Howard Thaler

0 references

Paul J. Sabbatini

7

Paul Sabbatini

0 references

William P Tew

10

William Tew

0 references

Martee L Hensley

8

Martee L. Hensley

0 references

Carol Aghajanian

6

Carol Aghajanian

0 references

Douglas A Levine

5

Douglas A. Levine

0 references

author name string

Zharna Shah

2

0 references

David Spriggs

11

0 references

Martin Fleisher

12

0 references

Jakob Dupont

14

0 references

language of work or name

English

0 references

publication date

February 2007

0 references

published in

Gynecologic Oncology

0 references

volume

104

0 references

issue

2

0 references

page(s)

435-442

0 references

cites work

Cancer statistics, 2006

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Early pathologic stage clear cell carcinoma and uterine papillary serous carcinoma of the endometrium: comparison of clinicopathologic features and survival.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Molecular and cytokinetic pretreatment risk assessment in endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Prognostic significance of progesterone receptor immunohistochemistry in endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Loss of PTEN expression is associated with metastatic disease in patients with endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

CA 15-3 as a tumor marker in gynecological malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Tissue and serum CA125 expression in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Preoperative CA 125 in endometrial cancer: is it useful?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Early detection and prognosis of ovarian cancer using serum YKL-40.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Purification and characterization of human chitotriosidase, a novel member of the chitinase family of proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Chitotriosidase, a chitinase, and the 39-kDa human cartilage glycoprotein, a chitin-binding lectin, are homologues of family 18 glycosyl hydrolases secreted by human macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Regulation of YKL-40 expression during genotoxic or microenvironmental stress in human glioblastoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Serum YKL-40 and colorectal cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

High serum YKL-40 levels in patients with primary breast cancer is related to short recurrence free survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

High serum YKL-40 level in patients with small cell lung cancer is related to early death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

High serum concentration of YKL-40 is associated with short survival in patients with acute myeloid leukemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Elevated serum level of YKL-40 is an independent prognostic factor for poor survival in patients with metastatic melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

A nonparametric test for association with censored data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Preoperative sensitivity and specificity for early-stage ovarian cancer when combining cancer antigen CA-125II, CA 15-3, CA 72-4, and macrophage colony-stimulating factor using mixtures of multivariate normal distributions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates directional migration of human umbilical vein endothelial cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

gp38k (CHI3L1) is a novel adhesion and migration factor for vascular cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028

Uterine papillary serous carcinoma: evaluation of multimodality treatment with abdominopelvic radiotherapy and chemotherapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2006.08.028